Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-30

Clinical Trial Update: Generating Evidence on NonEpileptic, Stereotypical and Intermittent Symptoms (NESIS) in Chronic Subdural Hematomas [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating NESIS in chronic subdural hematoma with associated epilepsy/seizure symptoms; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Université de Sherbrooke | Conditions: Chronic Subdural Hematoma, Epilepsy; Seizure | Phase 4 | Status: UNKNOWN